BALTIMORE, Md., March 7, 2014 — The Steering Committee of The University of Maryland, MPowering the State has named Teresa LaMaster, JD, MA, executive director, MPowering the State. In this newly created position, LaMaster will work to advance the growing educational and research …
Martha Connolly Will Enhance UMD-UMB Innovation Ecosystem COLLEGE PARK, Md., Jan. 6, 2014 — University of Maryland Ventures (UM Ventures) announced today that Dr. Martha J. Connolly has been named director of bioentrepreneurship, a new program supported by the Maryland …
November 13, 2013 Contact: Crystal Brown (UMD) 301-405-4621 crystalb@umd.edu Alex Likowski (UMB) 410-706-3801 alikowski@umaryland.edu New IBBR Director Envisions Premier Biotechnology Research Institute COLLEGE PARK, Md. – The University of Maryland today announced the appointment of Thomas R. Fuerst, Ph.D., …
Regulatory Science and Innovation Take Center Stage at One-Day Conference The University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI), offers a forum for scientists from the Food and Drug Administration (FDA), the University of Maryland community, and the public to …
UM Ventures catalyzes commercialization by engaging industry partners throughout the Baltimore/Washington metropolitan region BALTIMORE, MD, August 6, 2013 – University of Maryland (UM) Ventures announced today agreements between University of Maryland, Baltimore (UMB) and five different life sciences companies across …
University Recreation and Fitness (URecFit) at the University of Maryland, Baltimore (UMB) and the Department of Campus Recreation Services at the University of Maryland, College Park (UMCP) have agreed to provide access to recreation facilities to members of both campuses …
Baltimore, MD, July 17, 2013 – UM Ventures has signed a licensing agreement with Rockville, Md.-based Rexahn Pharmaceuticals, Inc. for a newly-developed cancer drug delivery platform, Nano-Polymer-Drug Conjugate Systems (NPDCS). The technology helps target cancer-fighting drugs directly to tumors, minimizing …
Public-private effort targets vaccines The Daily Record, Thursday, July 11, 2013 Fina Biosolutions LLC, of Rockville, a privately held developer of vaccines to combat life-threatening diseases, and Frank T. Robb, a scientist at the University of Maryland Institute of Marine …
An Interactive Seminar on Innovation to Stimulate the Brightest Minds from the University’s Baltimore and College Park Campuses Speaker: Sarah Bergbreiter PhD Assistant Professor Mechanical Engineering and Institute for Systems Research A. James Clark School of Engineering University of Maryland …
– PATH-Funded Public-Private Partnership Designed to Improve Vaccine Manufacturing Platform – University of Maryland (UM) Ventures announced today a collaboration between Frank Robb, Ph.D., at the Institute of Marine and Environmental Technology, and Department of Microbiology & Immunology at the …